BioSpace News Archive

BioInvent to Host Virtual KOL Event to Highlight Recently Presented Efficacy Data from BioInvent’s Lead Candidates BI-1808 and BI-1206

BioInvent International AB today announced that it will host a virtual KOL event on Tuesday, June 18, 2024 from 9:00-10:45 AM ET/3-4:45.

May 30, 2024
·
4 min read
Business

FluoGuide A/S Publishes Interim Report for the Period January - March 2024

FluoGuide A/S releases its results for the period 1 January - 31 March 2024.

May 30, 2024
·
2 min read
Crossject announces publication of clinical data on ZEPIZURE ® in Neurology and Therapy

Seizures require urgent treatment when they last longer than 5 minutes and when prolonged, can lead to damage to the brain, coma, and ultimately death.

May 30, 2024
·
3 min read
Business

Anocca AB and Shinobi Therapeutics Announce Strategic Partnership to Develop Allogeneic TCR-T Cell Therapies in Oncology

Anocca AB and Shinobi Therapeutics announced a strategic partnership to use Shinobi’s proprietary immune evasive iPS-T cell platform with novel candidate TCRs, discovered and validated by Anocca, to develop a new class of off-the-shelf allogeneic TCR engineered iPS-T-cell therapies for solid tumors.

May 30, 2024
·
4 min read
Business

Onc.AI to Present Collaboration Results Demonstrating Immunotherapy Response Prediction Using a Radiomic Signature in Late-Stage Lung Cancer

Onc.AI today announced that new data will be presented at the 2024 Annual Society of Clinical Oncology (ASCO) resulting from its collaboration with Pfizer.

May 30, 2024
·
2 min read
Business

Harness Therapeutics appoints Leading World Experts in Neurodegenerative Diseases to its Scientific Advisory Board (SAB)

Harness Therapeutics announces the formation of its new SAB, consisting of renowned leaders in the genetics, biology, and clinical development of Huntington’s disease and other important neurodegenerative disorders:

May 30, 2024
·
4 min read
Genetown

TScan Therapeutics Announces Upcoming Presentation at the 2024 Jefferies Global Healthcare Conference

TScan Therapeutics, Inc. announced that the Company will present at the Jefferies Global Healthcare Conference being held at the Marriott Marquis in New York, NY on Wednesday, June 5, 2024 at 11:00 a.m. Eastern Time.

May 30, 2024
·
1 min read
Genetown

Omega Therapeutics To Participate In Two Upcoming Investor Conferences - May 30, 2024

Omega Therapeutics, Inc. today announced that management will participate in fireside chats at two upcoming investor conferences.

May 30, 2024
·
1 min read
Business

LSL Pharma Group Reports Record Revenues and Margins for the First Quarter 2024

LSL PHARMA GROUP INC. (TSXV: LSL) (the “Corporation” or “LSL Pharma "), a Canadian integrated pharmaceutical company, today reported its financial results for the first quarter of fiscal year 2024 ended on March 31, 2024.

May 30, 2024
·
7 min read
Pharm Country

LAVA Therapeutics to Participate in the Jefferies Global Healthcare Conference

LAVA Therapeutics N.V. today announced that Stephen Hurly, President and Chief Executive Officer of LAVA Therapeutics, will participate in a fireside chat at the Jefferies Global Healthcare Conference.

May 30, 2024
·
1 min read